Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Picketts

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Neuro-Oncology Advances|February 27, 2023
Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of <i>Hoxa</i> cluster genes and promotion of neuronal lineageAalaa S Abdallah, Herminio J Cardona, Samantha L Gadd, et al.
Cell Reports|October 13, 2016
Voluntary Running Triggers VGF-Mediated Oligodendrogenesis to Prolong the Lifespan of Snf2h-Null Ataxic MiceMatías Alvarez-Saavedra, Yves De Repentigny, Doo Yang, et al.
Human Molecular Genetics|May 12, 2023
A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological defectsRebekah Tillotson, Keqin Yan, Julie Ruston, et al.
EMBO Reports|March 1, 2024
PHF6-mediated transcriptional control of NSC via Ephrin receptors is impaired in the intellectual disability syndrome BFLSDilan Rasool, Audrey Burban, Ahmad Sharanek, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Cancer Research|November 12, 2024
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or SomatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Theranostics|October 21, 2024
Single-cell profiling of brain pericyte heterogeneity following ischemic stroke unveils distinct pericyte subtype-targeted neural reprogramming potential and its underlying mechanismsAllison Loan, Nidaa Awaja, Margarita Lui, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Nature Communications|June 21, 2014
Snf2h-mediated chromatin organization and histone H1 dynamics govern cerebellar morphogenesis and neural maturationMatías Alvarez-Saavedra, Yves De Repentigny, Pamela S Lagali, et al.
Nature Communications|November 10, 2025
Pathogenic variants in SMARCA1 cause an X-linked neurodevelopmental disorder modulated by NURF complex compositionGhayda M Mirzaa, Keqin Yan, Raissa Relator, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Neuro-Oncology Advances|February 27, 2023
Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of <i>Hoxa</i> cluster genes and promotion of neuronal lineageAalaa S Abdallah, Herminio J Cardona, Samantha L Gadd, et al.
Cell Reports|October 13, 2016
Voluntary Running Triggers VGF-Mediated Oligodendrogenesis to Prolong the Lifespan of Snf2h-Null Ataxic MiceMatías Alvarez-Saavedra, Yves De Repentigny, Doo Yang, et al.
Human Molecular Genetics|May 12, 2023
A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological defectsRebekah Tillotson, Keqin Yan, Julie Ruston, et al.
EMBO Reports|March 1, 2024
PHF6-mediated transcriptional control of NSC via Ephrin receptors is impaired in the intellectual disability syndrome BFLSDilan Rasool, Audrey Burban, Ahmad Sharanek, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Cancer Research|November 12, 2024
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or SomatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Theranostics|October 21, 2024
Single-cell profiling of brain pericyte heterogeneity following ischemic stroke unveils distinct pericyte subtype-targeted neural reprogramming potential and its underlying mechanismsAllison Loan, Nidaa Awaja, Margarita Lui, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Nature Communications|June 21, 2014
Snf2h-mediated chromatin organization and histone H1 dynamics govern cerebellar morphogenesis and neural maturationMatías Alvarez-Saavedra, Yves De Repentigny, Pamela S Lagali, et al.
Nature Communications|November 10, 2025
Pathogenic variants in SMARCA1 cause an X-linked neurodevelopmental disorder modulated by NURF complex compositionGhayda M Mirzaa, Keqin Yan, Raissa Relator, et al.
Pageof 6